Two Sigma Investments
GALT icon

Two Sigma Investments’s Galectin Therapeutics GALT Stock Holding History

Two Sigma Investments’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Buy
467,063
+450,451
+2,712% +$1.37M ﹤0.01% 3059
2025
Q4 		$69.1K Sell
16,612
-35
-0.2% -$184 ﹤0.01% 3894
2025
Q3 		$70.5K Buy
+16,647
New +$62.6K ﹤0.01% 3509
2021
Q1 		– Sell
-60,181
Closed -$135K – 4024
2020
Q4 		$135K Sell
60,181
-61,403
-51% -$161K ﹤0.01% 3179
2020
Q3 		$325K Buy
121,584
+45,394
+60% +$127K ﹤0.01% 2538
2020
Q2 		$233K Buy
76,190
+59,258
+350% +$149K ﹤0.01% 2539
2020
Q1 		$33K Buy
+16,932
New +$41.2K ﹤0.01% 2953

Other funds holding GALT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM